SLRX NASDAQ

Salarius Pharmaceuticals, Inc. - Common Stock

Healthcare · Biotechnology
$0.66
▼ $-0.03 (-3.73%)
Vol 40K
2
Quality Score
fail
Mkt Cap
$4.1M
ROE
-208.5%
Margin
-179.1%
D/E
0.00
Beta
0.37
52W
$1–$108

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -324.1% -324.1% -324.1% -324.1% -208.5%
P/E (TTM) — — — — — —
Net Margin — -179.1% -179.1% -179.1% -179.1% -179.1%
Gross Margin — 48.6% 48.6% 48.6% 48.6% 48.6%
D/E Ratio — 181.40 181.40 181.40 181.40 0.00
Current Ratio 0.61 0.61 0.61 0.61 0.61 3.28

Key Ratios

ROA (TTM)
-155.8%
P/S (TTM)
0.88
P/B
1.8
EPS (TTM)
$-25.01
CF/Share
$-6.49
52W High
$108.00
52W Low
$0.62
$0.62 52-Week Range $108.00

How does SLRX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SLRX AAPG ABEO ABOS ABP

SLRX valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.9
▼ 93% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.8
▼ 29% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SLRX profitability vs Biotechnology peers

ROE
-208.5%
▼ 210% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-179.1%
▲ 38% above peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
48.6%
▼ 38% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-155.8%
▼ 233% below peers (-46.7%)
vs Peers
vs Industry
Weak

SLRX financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.3
▼ 26% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.4
▼ 62% below peers (1.0)
vs Peers
vs Industry
More volatile

SLRX fundamentals radar

SLRX Peer median Industry

SLRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SLRX vs peers: key metrics

Latest News

No related news yet